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Research
Recent epidemiologic studies have shown
associations between ambient particle concen-
trations and changes in heart rate variability
(HRV), a measure of autonomic function. In
panel studies of healthy senior citizens
(Creason et al. 2001; Gold et al. 2000), cardiac
patients (Liao et al. 1999; Pope et al. 1999),
and healthy adult boilermakers (Magari et al.
2001), airborne particles were associated with
decreased HRV, a known risk factor for sud-
den death. Conﬂicting results were found in a
study of seniors with chronic obstructive pul-
monary disease (COPD), which showed no
associations between HRV and particulate
matter < 10 μm aerodynamic diameter (PM10)
and PM2.5 (Brauer et al. 2001), and in a study
of healthy young highway patrolmen, which
showed strong increases in HRV with PM2.5
exposures (Riediker et al. 2004). Results from
these studies suggest that compromised auto-
nomic control of the heart may play a role in
the acute cardiovascular toxicity of particles
but that this role may differ with the underly-
ing health status of the individual. The impact
of health status on the relationship between
HRV and ambient PM, however, has not been
examined directly, with panel studies con-
ducted to date including participants of only
one susceptible disease group. To examine this
issue more directly, we conducted a study to
evaluate associations between ambient fine
particles (PM2.5) and HRV for sensitive indi-
viduals and examine whether these associa-
tions differed for individuals with preexisting
pulmonary disease compared with those with
cardiovascular disease.
Materials and Methods
In fall 1999 and spring 2000, repeated health
and exposure measurements were made under
a protocol approved by the Harvard School of
Public Health Human Subjects Committee.
Measurements were made for individuals liv-
ing in metropolitan Atlanta, Georgia, who had
a myocardial infarction (MI) 3–12 months
before the start of the study or had self-
reported, physician-diagnosed moderate-to-
severe COPD. Each of these individuals
provided informed consent to participate in
the study. Data for this analysis were collected
as part of a more comprehensive investigation
designed to examine the cardiovascular health
effects of fine particles. Measurements were
made for each participant over 7 consecutive
days in one or both seasons, with health meas-
urements made each morning and exposure
measurements made each day, beginning
24 hr before the health measurements. Five
participants were monitored simultaneously
each 7-day period. Twenty-four and 22 indi-
viduals participated in the fall and spring,
respectively, with 13 individuals (6 with MI,
7 with COPD) participating in both seasons.
A total of 30 individuals (12 individuals with
a recent MI and 18 individuals with COPD)
participated in the study.
Participant recruitment and baseline
health assessment. Participants were recruited
from a number of locations in the metropoli-
tan Atlanta area; the primary method for
recruitment was through physician clinics and
rehabilitation centers. Once the individual
had expressed interest in participating and his
or her primary care physician had granted
approval, several screening procedures were
undertaken. These included questionnaires on
medical history, medication use, housing
characteristics, and vitamin use; baseline
spirometry; and a resting 12-lead electro-
cardiogram (ECG) (MAC6; Marquette
Medical Systems Inc., Milwaukee, WI, USA).
Exclusion criteria were similar to those of the
Boston, Massachusetts, HRV study conducted
by Gold et al. (2000) and included unstable
angina, atrial ﬂutter, atrial ﬁbrillation, paced
rhythm, left bundle branch block, on constant
oxygen, smoking or living with smokers, and
inability to walk on level ground. Two partici-
pants were unable to successfully complete the
pulmonary function maneuver; as a result,
baseline spirometry measurements were
obtained for 28 of the 30 participants.
Health monitoring. Field technicians vis-
ited participants in their homes between
0700 hr and 1100 hr on each monitoring day.
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Associations between concentrations of ambient ﬁne particles [particulate matter < 2.5 µm aero-
dynamic diameter (PM2.5)] and heart rate variability (HRV) have differed by study population. We
examined the effects of ambient pollution on HRV for 18 individuals with chronic obstructive pul-
monary disease (COPD) and 12 individuals with recent myocardial infarction (MI) living in
Atlanta, Georgia. HRV, baseline pulmonary function, and medication data were collected for each
participant on 7 days in fall 1999 and/or spring 2000. Hourly ambient pollution concentrations
were obtained from monitoring sites in Atlanta. The association between ambient pollution and
HRV was examined using linear mixed-effect models. Ambient pollution had opposing effects on
HRV in our COPD and MI participants, resulting in no signiﬁcant effect of ambient pollution on
HRV in the entire population for 1-, 4-, or 24-hr moving averages. For individuals with COPD,
interquartile range (IQR) increases in 4-hr ambient PM2.5 (11.65 µg/m3) and nitrogen dioxide
(11.97 ppb) were associated with 8.3% [95% conﬁdence interval (CI), 1.7–15.3%] and 7.7% (95%
CI, 0.1–15.9%) increase in the SD of normal R-R intervals (SDNN), respectively. For individuals
with MI, IQR increases in 4-hr PM2.5 (8.54 µg/m3) and NO2 (9.25 ppb) were associated with a
nonsigniﬁcant 2.9% (95% CI, –7.8 to 2.3) and signiﬁcant 12.1 (95% CI, –19.5 to –4.0) decrease
in SDNN. Beta-blocker and bronchodilator intake and baseline forced expiratory volume in 1 sec
modified the PM–SDNN association significantly, with effects consistent with those by disease
group. Results indicate heterogeneity in the autonomic response to air pollution due to differences
in baseline health, with signiﬁcant associations for ambient NO2 suggesting an important role for
trafﬁc-related pollution. Key words: ambient pollution, chronic obstructive pulmonary disease, ﬁne
particulate matter, heart rate variability, myocardial infarctions, nitrogen dioxide. Environ Health
Perspect 114:560–566 (2006). doi:10.1289/ehp.8337 available via http://dx.doi.org/ [Online
15 November 2005]At the beginning of each visit, ﬁeld technicians
administered a questionnaire on health status,
medication use, vitamin intake, housing
characteristics, and activity patterns. Field tech-
nicians subsequently placed a Holter monitor
(SEER MC ambulatory digital analysis
recorder; GE Medical Systems, Milwaukee,
WI, USA) on each participant and led the par-
ticipant through a standardized HRV protocol.
The HRV protocol included continuous
Holter monitoring using electrodes in a mod-
ified V5 and AVF position. The participant
also wore a blood oximeter throughout the
protocol (N-20P Oximeter; Nellcor, CA,
USA). While wearing these devices, partici-
pants were asked to follow a standardized pro-
tocol (Gold et al. 2000) in which they were
asked to rest in the supine position for 5 min,
stand for 5 min, walk outside for 5 min, rest
in the supine position for 5 min, and ﬁnally
to perform paced breathing (5 sec inhalation
and 5 sec exhalation) for 20 inhalation and
exhalation cycles of 5 sec while being coached
by a technician. The paced breathing portion
of the protocol was designed to evaluate
whether the effects of pollution on HRV were
independent of respiratory rate, which might
also be inﬂuenced by pollution levels, and to
bring out vagal tone in the assessment of
HRV. This standardized protocol has been
used in other studies speciﬁcally for the evalu-
ation of HRV (Sullivan 2005). During each
of the 5-min protocol portions, respiratory
rate was measured, followed by two blood
pressure readings using an automated blood
pressure machine (NIBP Vital Signs Monitor;
Welch Allyn, Skaneateles Falls, NY, USA).
The blood pressure readings during the stand-
ing portion of the protocol were taken after
2 min of standing had elapsed. After the out-
door exercise, the order of the blood pressure
readings and respiratory rate was reversed.
We analyzed the Holter tapes using a
Marquette MARS Workstation (Marquette
Medical Systems, Milwaukee, WI, USA), with
a sampling rate of 125 samples/sec, which is
standard for routine HRV analyses and is
“satisfactory” under the HRV guidelines (Task
Force of the European Society of Cardiology
and the North American Society of Pacing
and Electrophysiology 1996). All analyses
were reviewed by a trained technician for noise
and artifact. Ectopic beats were excluded in
these analyses, with a linearly interpolated
QRS based on the prior beat’s R-R interval
and the subsequent beat’s R-R interval
inserted, as is standard. Holter tapes were ana-
lyzed for several measures of HRV, including
both time and frequency domain outcomes.
Time domain outcomes included the standard
deviation of normal R-R intervals (SDNN),
the square root of the mean of the sum of
squares of differences between adjacent NN
intervals (RMSSD), and the percentage of the
absolute differences between successive normal
R-R intervals that exceed 50 msec (PNN50).
Frequency domain variables included high-
frequency power of 0.15–0.40 Hz (HF) and
low-frequency power of 0.04–0.15 Hz (LF).
A total of 300 Holter monitoring sessions
were completed for 31 subjects, 28 of whom
had five or more measurements. Of the 300
observations, 25 observations were excluded
because of onset of atrial fibrillation, three
because of second-degree block, and three
were unreadable. One participant was subse-
quently excluded from all analyses because of
atrial ﬁbrillation. Of the 300 valid Holter ses-
sions, three sessions were missing portions of
the overall protocol. These sessions were not
excluded from subsequent data analyses
because results did not differ based on their
inclusion in the model.
Pollution measurements. Hourly pollu-
tion and meteorologic data were obtained
from sites located within the metropolitan
Atlanta area that were operated as part of
other studies (Figure 1). Hourly ambient
PM2.5 concentrations were measured at the
Yorkville, Fort McPherson, and Tucker sta-
tionary ambient monitoring (SAM) sites,
which were operated as part of the Assessment
of Spatial Aerosol Composition in Atlanta
and Southeastern Aerosol Research and
Characterization studies (National Research
Council 1999). Sites were located throughout
the metropolitan Atlanta area and were char-
acterized by a variety of land uses. Tucker is
classified as a suburban/commercial site,
Yorkville as a rural site, and Fort McPherson
as an urban site. Hourly PM2.5 concentrations
were measured at these sites using a tapered
element oscillating microbalance with a
Nafion dryer placed upstream of the inlet
(R&P, Albany, NY, USA). Hourly ozone con-
centrations were measured using methods
approved by the U.S. Environmental
Protection Agency (U.S. EPA 2004) at SAM
sites located at Tucker, Yorkville, and South
Dekalb, a suburban site, whereas hourly car-
bon monoxide, sulfur dioxide, and nitrogen
dioxide concentrations were measured using
U.S. EPA-approved methods (U.S. EPA
2004) at the Tucker and South Dekalb sites.
Black carbon (BC) concentrations were meas-
ured using aethalometers at the Jefferson St.
SAM site located in downtown Atlanta in a
mixed industrial and residential site that was
operated as part of the Aerosol and Inhalation
Epidemiological Study network. Meteorologic
data, including temperature and relative
humidity, were also obtained from the
Jefferson St. SAM site.
Analyses were conducted using three
exposure periods: the hour during the
recorded HRV protocol and the 4- and 24-hr
mean before the HRV protocol. Calculated 4-
and 24-hr mean exposures were considered
valid when data for > 3 hr or > 18 hr (75% of
the hours), respectively, were available.
Because participant homes and SAM sites
were located throughout metropolitan
Atlanta, the average concentration for the
available SAM sites was used as the PM2.5 and
gaseous exposure measure. Exposure data
were void if data were available from only one
SAM site. Under these criteria, 100%, 84%,
89%, 91%, and 95% of the observations were
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Figure 1. Locations of participants’ homes and the SAM sites, Atlanta, Georgia.
Abbreviations: FT, Fort McPherson; JST, Jefferson St.; SDe, South Dekalb; TU, Tuckerville; YRK, Yorkville.
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evalid for 4-hr exposures to PM2.5, NO2, CO,
SO2, and O3, respectively.
Data analysis. We examined the associa-
tion between ambient pollution and HRV (for
the entire 35-min period) using linear mixed-
effect models. The HRV outcomes measured
in the models were log transformed. Models
controlled for time, meteorologic, and sub-
ject-related variables, including random
effects for subjects, and adjusting for body
mass index (BMI), temperature, and relative
humidity as continuous variables and sex, age,
medication use, season, hour, and day of
week as categorical variables. Medication use
was included as a categorical variable for four
medication types: beta-blockers, calcium
channel blockers, angiotensin-converting
enzyme (ACE) inhibitors, and broncho-
dilators (nonsteroidal long- and short-acting),
with values based on whether the participant
was or was not prescribed the medication.
Because the relationship between weather and
the outcome variables was nonlinear, both
temperature and relative humidity were mod-
eled using natural spline functions with
3 degrees of freedom. Models did not control
for heart rate, which is inversely associated
with HRV. When heart rate was included in
the model, model results were similar,
although with slightly lower coefﬁcients.
To identify factors that modify the associ-
ation between HRV and ambient pollution,
parameters, including disease status, baseline
pulmonary function, medication use, respira-
tory rate, air conditioning use, exercise during
the protocol, BMI, age, and heart rate, were
included separately in models. Medication use
was controlled for in these models, with the
exception of models examining effect modiﬁ-
cation by medication use. Because only indi-
viduals with COPD took bronchodilator
medications, models that were stratified by
disease status did not control for broncho-
dilator medications. Analyses of pollution and
HRV were conducted with data combined
across seasons. All statistical analyses were con-
ducted using S-Plus (Insightful Corporation,
Seattle, WA, USA). Unless otherwise indi-
cated, statistical significance was determined
based on a p-value of 0.05.
Results
Participant profiles. Measurements were
obtained for 30 individuals, 12 with recent MIs
(3–6 months post-MI) and 18 with self-
reported, physician-diagnosed moderate-to-
severe COPD. In total, 265 observations were
obtained over all participants, 159 for those
with COPD and 106 for those with a recent
MI. Participants lived throughout metropolitan
Atlanta (Table 1). As shown in Table 1, the
COPD participants were generally older, with a
higher percentage of females compared with the
MI cohort. As would be expected, the COPD
cohort had lower baseline lung function [forced
expiratory volume in 1 sec (FEV1)]. Medication
use differed by disease group, with bronchodila-
tors taken only by individuals with COPD and
beta-blockers taken by a higher fraction of indi-
viduals with a recent MI. Fewer COPD partici-
pants were never-smokers.
Ambient pollution concentrations. Ambient
pollution levels varied substantially across the
monitoring period (Table 2), with similar dis-
tributions for the fall and spring monitoring
seasons. Distributions of 1-hr (not shown) and
24-hr ambient pollution concentrations were
comparable to corresponding 4-hr values.
Four-hour PM2.5 concentrations were signiﬁ-
cantly correlated with 4-hr NO2 (r = 0.44,
p < 0.001) and CO (r = 0.43, p < 0.001) con-
centrations in both seasons, with correlations
strongest in the fall for both pollutants. In
both seasons, 4-hr PM2.5 concentrations were
also signiﬁcantly correlated with correspond-
ing elemental carbon (EC) levels (r = 0.51,
p < 0.001). Correlations were also strong
among 4-hr ambient EC, NO2, and CO con-
centrations (rEC-NO2 = 0.67, p < 0.001; rEC-CO
= 0.59, p < 0.001; rNO2-CO = 0.46, p < 0.001),
likely because motor vehicles are the major
source for these pollutants outdoors.
For PM2.5, 4-hr mean concentrations were
lowest at the rural Yorkville site (13.2 ±
7.6 μg/m3) compared with the Tucker (21.9 ±
10.5 μg/m3) and Fort McPherson (18.5 ±
9.1 μg/m3) SAM sites. Despite these differ-
ences, their concentrations were strongly cor-
related, with Spearman correlation coefﬁcients
> 0.75 for comparisons among the SAM sites
and > 0.89 for comparisons of the individual
site concentrations with the mean concentra-
tion across the sites. Although mean 4-hr con-
centrations were comparable across sites,
correlations among the sites’ 4-hr NO2 con-
centrations were more moderate but remained
signiﬁcant, with a Spearman correlation coefﬁ-
cient for a comparison of Tucker and South
Dekalb concentrations of 0.44 and coefﬁcients
for comparisons with the mean NO2 concen-
tration across the two sites > 0.72. Four-hour
mean O3 concentrations differed substantially
across the sites, with mean levels highest at
Yorkville (33.8 ± 12.6 ppb), followed by
Tucker (14.5 ± 10.5 ppb) and South Dekalb
(8.0 ± 9.2 ppb) sites. Correlations among the
sites were also weaker, primarily due to the
low correlations observed for the rural
Yorkville site (0.30 and 0.00 for Yorkville–
Tucker and Yorkville–South Dekalb compari-
sons, respectively).
For EC, because hourly ambient EC con-
centrations were measured only at the Jefferson
St. SAM site, spatial variability was evaluated
using 24-hr ambient EC concentrations meas-
ured at the Yorkville and Jefferson St. SAM
sites. The mean 24-hr concentration at
Jefferson St. (1.81 ± 1.06 μg/m3) was approxi-
mately twice that for YRK (0.77 ± 0.45 μg/m3),
which is consistent with the fact that Jefferson
St. was located in an urban/suburban area and
Yorkville was located in a rural area. Despite
these differences in mean levels, 24-hr EC con-
centrations at these sites were moderately corre-
lated during the study period, with a signiﬁcant
Spearman correlation of 0.47.
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Table 2. Summary of meteorologic and air pollution levels.
Percentile
Parametera No. Mean 10th 25th 50th 75th 90th 24 hrb
Meteorology (24 hr)
Temperature (°C) 265 17.8 12.2 16.1 18.0 20.3 23.6 —
Relative humidity (%) 265 70.3 52.5 57.4 70.1 82.6 92.6 —
Pollution (4 hr)
PM2.5 (µg/m3) 264 17.8 7.0 11.6 16.5 22.2 30.9 17.2
EC (µg/m3) 260 2.3 0.9 1.2 1.6 2.9 4.4 2.0
O3 (ppb) 251 18.5 9.0 12.7 17.0 22.5 30.3 29.4
CO (ppb) 236 362.0 169.7 221.5 304.3 398.1 682.1 332.1
SO2 (ppb) 240 1.9 0.7 0.9 1.5 2.4 3.6 2.5
NO2 (ppb) 222 17.8 7.1 12.0 17.0 22.8 29.8 17.1
aValues correspond to the mean for the 24-hr or 4-hr periods before the HRV measurements. bCorresponding 24-hr mean val-
ues for time period before the health measurements.
Table 1. Participant characteristics by disease status.
Disease group
Characteristic COPD MI Alla
Sexb
Male 7 10 30
Female 11 2
Age (years)c
Male 74 (71–76) 59 (49–70)
65 (55–73) Female 64 (49–75) 69 (66–71)
FEV1(% predicted)c,d
Male 67 (43–80) 99 (86–115) 69 (44–98)
Female 45 (36–59) 96 (91–101)
BMIc 27 (22–31) 27 (25–28) 27 (25–29)
Medication usea
Beta-blockers 1 8 9
Calcium channel 4 3 7
blockers
ACE inhibitors 3 6 9
Bronchodilators, 12 0 12
short actinge
Bronchodilator, 5 0 5
long actingf
aTotals for all participants. bExpressed as number of par-
ticipants. cExpressed as mean (interquartile range). dDoes
not include data for two participants, for which baseline
pulmonary function could not be measured. eAlbuterol,
salmeterol, pirbuterol, ipratropium bromide and albuterol,
and ipratropium bromide. fTheophylline.HRV outcomes. Several of the HRV out-
comes varied significantly by disease group
(Table 3). Individuals with COPD, for exam-
ple, had signiﬁcantly lower SDNN and LF val-
ues compared with individuals with a recent
MI as determined using the Wilcoxon rank
sum test (p = 0.012 and 0.0003, respectively).
Heart rate, a potential modiﬁer of HRV, was
lower in the MI group (p < 0.0001), which
may reﬂect beta-blocker use in the MI cohort.
For all other outcomes, comparable values
were found across disease group.
Association between PM2.5 and HRV. The
association between ambient PM2.5 and
SDNN was positive for individuals with
COPD, with associations strongest for the 4-hr
moving average (Table 4). For the 4-hr mov-
ing average, SDNN rose by 7.5% (95% CI,
1.5–13.9%) per interquartile range (IQR)
increase in ambient PM2.5 (10.64 μg/m3). In
comparison, opposing effects of ambient PM2.5
on HRV were found in individuals who were
post-MI, resulting in no significant overall
summary effect of ambient PM2.5 on HRV in
the entire population for moving averages of
1-, 4-, or 24-hr (Table 4). When these analyses
were performed using models that included an
interaction term between PM2.5 and disease
status, the disease group-specific effects of
ambient PM2.5 on HRV were similar to those
obtained from our stratified analyses, with a
significant interaction term. As shown in
Table 5, associations of PM2.5 and other HRV
measures, RMSSD, PNN50, LF, HF, and
LF:HF ratio, generally followed similar trends
by disease status, with associations signiﬁcant
only for LF in individuals with COPD.
Association between HRV and other pollu-
tants. Four-hour ambient NO2 concentrations
were associated with changes in SDNN when
analyses were stratified by disease status
(Table 6), with results exhibiting trends con-
sistent with those for ambient PM2.5. Effect
sizes for NO2 were similar to those observed
for ambient PM2.5 for individuals with
COPD and were larger and more precise than
those observed for ambient PM2.5 for individ-
uals with an MI. An IQR increase in 4-hr
NO2 concentrations (10.75 ppb) was associ-
ated with a 6.9% (95% CI, 0.1–14.2) increase
in SDNN in individuals with COPD and a
13.9% (95% CI, –22.2 to –4.7) decrease in
SDNN in persons with a recent MI. For EC,
trends consistent with those for ambient
PM2.5 and NO2 were observed; however, asso-
ciations were insigniﬁcant. Ambient O3 con-
centrations were not associated with SDNN
when data were examined for all subjects or
were stratiﬁed by disease group (Table 6).
Effect modiﬁcation by additional diagnosis-
related end points. The effect of medication
use, respiratory rate, baseline pulmonary func-
tion (as measured by FEV1), air conditioning
use, exercise during HRV measurement, BMI,
age, and heart rate on the association between
4-hr ambient pollution and overall SDNN was
examined to determine whether these factors
was responsible for the differences in response
between the disease groups. Of these, medica-
tion use and baseline FEV1 were found to be
signiﬁcant effect modiﬁers for 4-hr PM2.5 and
NO2 concentrations, with results comparable
for the two pollutants (Table 7). Similar effect
modiﬁcation by medication use and baseline
pulmonary function was also found for EC but
with smaller effect sizes.
Baseline FEV1. Consistent with the results
by disease group, baseline FEV1 (percent pre-
dicted) signiﬁcantly modiﬁed the association
between SDNN and 4-hr ambient PM2.5 and
NO2 among all participants, with the PM2.5–
SDNN association increasing with decreasing
baseline FEV1. Coefﬁcients for the main pol-
lution effect and the FEV1 interaction term
equaled 0.015 ± 0.004 (mean ± SE; t-value
= 3.46) and –0.0002 ± 0.0001 (t-value =
–3.18), respectively. For individuals with poor
pulmonary function (baseline FEV1 35% of
predicted; 10th percentile for study popula-
tion), these values corresponded to a 10.2%
increase in SDNN for an IQR increase in 4-hr
ambient PM2.5 concentrations, whereas for
individuals with normal pulmonary function
(baseline FEV1 105% of predicted; 90th per-
centile for the study population), these values
corresponded to a 2.5% decrease in SDNN
for the same IQR increase in PM2.5 (Table 7).
Medication use. Beta-blocker and broncho-
dilator use on the health measurement day
signiﬁcantly modiﬁed the association between
4-hr ambient PM2.5 and NO2 concentrations
and SDNN (Figure 2). SDNN decreased by
7.3% (95% CI, –13.8 to –0.35) for subjects
taking beta-blockers and increased by 5.8%
(95% CI, 0.91–10.8) for other subjects with
an IQR increase in 4-hr ambient PM2.5.
Responses were consistent in direction with
those for individuals with an MI and COPD,
respectively. Opposite patterns were observed
for subjects taking bronchodilator medications,
where positive SDNN–PM2.5 associations
were found for those on the medication and
negative associations were found for other sub-
jects. The effect sizes for PM2.5-associated
changes in SDNN for individuals taking medi-
cations were higher in magnitude compared
with effect sizes for corresponding individuals
with MI or COPD alone. Medications that
were taken by individuals from both disease
groups, including ACE inhibitors and calcium
channel blockers, were not found to modify
the SDNN–PM2.5 association signiﬁcantly.
Effect of spatial variability on effect
estimates. The effect of spatial variability in
ambient PM2.5 on observed associations
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Table 3. HRV [mean (10th percentile, 90th percentile)] by disease status.a
HRV parameter COPD (n = 18) MI (n = 12)
SDNN (msec) 104.4 (55.2, 186.2) 114.8 (63.8, 207.4)
RMSSD (msec) 44.5 (14.4, 129.4) 39.2 (12.6, 115.2)
PNN50 (%) 10.0 (0.4, 30.9) 6.4 (0.2, 23.2)
LF (msec2) 759.1 (62.8, 3700.6) 808.1 (115.5, 2726.2)
HF (msec2) 333.4 (36.1, 1278.1) 361.0 (49.8, 1356.9)
LF:HF ratio 2.5 (1.1, 6.8) 3.7 (0.9, 7.4)
Heart rate (bpm) 80.9 (64.2, 105.7) 68.6 (54.0, 86.7)
aIncludes data for all participants in both seasons; means and 10th and 90th percentiles expressed as the values for the
participant means.
Table 4. Association between ambient PM2.5 and
overall SDNN.
PM2.5 IQR Percent
integration period (µg/m3) change 95% CI
1 hr 10.3 1.50 –2.22 to 5.36
MI only 9.74 –2.75 –7.93 to 2.72
COPD only  10.66 5.07* 0.01 to 10.38*
4 hr 10.63 1.97 –2.30 to 6.43
MI only 8.54 –2.89 –7.79 to 2.27
COPD only 11.65 8.29* 1.71 to 15.30*
24 hr 8.00 –1.00 –4.67 to 2.82
MI only 8.05 –4.38 –9.42 to 0.94
COPD only 7.84 1.58 –3.59 to 7.01
Percent change in overall SDNN (with 95% CIs) expressed
per IQR change in ambient PM2.5. Model does not include
heart rate. 
*Statistically signiﬁcant estimate.
Table 5. Association between ambient 4-hr PM2.5
and other HRV parameters.
Percent
HRV measure change 95% CI t-Value
SDNN 1.97 –2.30 to 6.43 0.90
MI –2.89 1.71 to 2.27  –1.11
COPD 8.29* –7.79 to 15.30 2.49
RMSSD –0.92 –10.19 to 9.30 –0.18
MI –11.38 –23.03 to 2.03 –1.68
COPD 9.77 –5.37 to 27.35 1.23
PNN50 –2.96 –18.15 to 15.03 –0.35
MI –10.18 –29.94 to 15.17 –0.85
COPD –1.19 –21.07 to 23.70 0.10
LF 14.04 –1.84 to 32.49 1.72
MI 1.12 –15.52 to 21.03 0.12
COPD 35.88* 6.79 to 72.90 2.49
HF 5.03 –9.96 to 22.52 0.62
MI –6.48 –25.68 to 17.70 –0.57
COPD 19.41 –4.05 to 48.59 1.59
LF:HF ratio 1.85 –4.91 to 9.09 0.52
MI –1.28 –9.16 to 7.28 –0.30
COPD 6.68 –4.02 to 18.59 1.20
Data are percent change in HRV (overall protocol)
expressed per IQR change in 4-hr ambient PM2.5. IQR
changes were 10.6, 8.5, and 11.7 µg/m3 for the 4-hr mean of
the SAM sites for all, MI, and COPD participants, respec-
tively. Model does not include heart rate. 
*Statistically signiﬁcant estimate.Wheeler et al.
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between overall SDNN and ambient PM2.5
and ambient NO2 was analyzed using data
from each of the individual SAM sites. For
PM2.5, spatial variability in ambient concen-
trations had little effect on the observed associ-
ations because both the magnitude and
direction of the association between SDNN
and 4-hr ambient PM2.5 were comparable
across sites (Table 8). These results are consis-
tent with the strong correlations among the
sites’ PM2.5 concentrations, with Spearman
correlation coefficients > 0.87 for pairwise
comparisons of the 4-hr concentrations at the
individual sites with the 4-hr across-site mean
concentrations. Results suggest that, for
PM2.5, the mean ambient SAM PM2.5 con-
centration is a good indicator of ambient
PM2.5 across the metropolitan Atlanta area.
For NO2, we found similar trends by dis-
ease status when associations were estimated
using data for the individual SAM sites com-
pared with the mean of these sites (Table 8).
The magnitude and signiﬁcance of the associ-
ations, however, dropped, with associations
for individuals with MIs no longer signiﬁcant
when measurements at the South DeKalb site
were used in the analysis. These ﬁndings sug-
gest greater exposure error when measure-
ments from single SAM sites were used to
reﬂect exposures for our study population.
Discussion
Findings from our study provide direct evi-
dence of heterogeneity in the autonomic
response to ambient pollution that is depen-
dent on the underlying health status of the
study population. Changes in HRV were sig-
niﬁcantly and positively associated with ambi-
ent PM2.5 concentrations for individuals with
COPD. Although not statistically signiﬁcant,
observed associations were consistently nega-
tive for individuals with recent MI. Further
support that the HRV response to ambient
PM2.5 differs for individuals with MI and
COPD was provided by the fact that we found
comparable effect estimates, with significant
differences between disease groups, using mod-
els that included an interaction term between
pollution and disease status. Associations with
ambient PM2.5 were strongest for the 4-hr
moving average and for SDNN, an overall
measure of HRV, although consistent trends
with disease status were observed for other
moving averages and other HRV measures,
including RMSSD, HF, and the LF:HF ratio.
We also observed strong and signiﬁcant associ-
ations with SDNN by disease group with
ambient NO2, and to a lesser extent with
ambient EC. Because ambient NO2 and EC
originate primarily from motor vehicles, our
ﬁndings suggest that motor vehicle-related pol-
lution may be partly responsible for the
observed effects of ambient particles on HRV.
Because results were similar irrespective of
whether models controlled for heart rate and
because heart rate did not modify the PM2.5–
HRV association, results suggest that the
observed effect modiﬁcation by disease status
was due to factors other than differences in
heart rate. For individuals with recent MI, the
negative, albeit insignificant, association
observed between ambient PM2.5 and HRV
was consistent with previous studies of elderly
Table 6. Association between 4-hr EC, NO2, and O3
concentrations and overall SDNN.
Percent
Pollutant IQR change 95% CI
EC 1.68 –0.83 –3.27 to 1.67
MI only 1.39 –1.06 –4.19 to 2.16
COPD only 1.92 0.51 –3.33 to 4.51
NO2 10.66 –0.49 –5.4 to 4.6
MI only 9.25 –12.09* –19.5 to –4.0
COPD only 11.97 7.70* 0.1 to 15.9
O3 9.61 0.75 –3.6 to 5.3
MI only 8.08 0.13 –6.5 to 7.2
COPD only 10.66 2.45 –3.4 to 8.7
Data are percent change in overall SDNN (with 95% CIs)
expressed per IQR change in pollutant concentrations.
Units for IQR are µg/m3 for EC, and ppb for O3 and NO2.
Model does not include heart rate.
*Statistically signiﬁcant estimate.
Table 7. Association of SDNN and ambient 4-hr
concentrations: baseline FEV1 (percent predicted)
as an effect modiﬁer.
Percent
Pollutant FEV1 change 95% CIa
PM2.5 (10.6 µg/m3) 105 –2.5 –7.8 to 3.2
35 10.2* 3.8 to 17.0
EC (1.7 µg/m3) 105 –3.9* –7.4 to –0.3
35 2.5 –1.3 to 6.4
NO2 (10.7 ppb) 105 –5.4 –12.0 to 1.8
35 5.7 –1.2 to 12.9
O3 (9.6 ppb) 105 –0.4 –7.1 to 6.8
35 1.1 –4.1 to 6.6
aExpressed as a change per IQR for the 4-hr mean ambient
concentration.
*Statistically signiﬁcant association.
Figure 2. Percent change in SDNN with 4-hr PM2.5 (A) and NO2 (B), expressed with 95% CI per IQR change
in PM2.5 (10.64 µg/m3) or NO2 (10.75 ppb). Medication use status is based on whether participant took medi-
cation on the morning of the health measurement. All percent changes differed signiﬁcantly by medication
use at p = 0.05.
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Table 8. Association between ambient 4-hr PM2.5 and SDNN by SAM site.
Pollutant/SAM Percent
site IQR change 95% CI t-Value
PM2.5
Mean of SAM sites 10.63 1.97 –2.30 to 6.43 0.90
MI 8.54 –2.89 –7.79 to 2.27 –1.11
COPD 11.65 8.29* 1.71 to 15.30 2.49
Tucker 15.40 1.74 –3.2 to 6.9 0.68
MI 14.33 –3.59 –10.3 to 3.6 –1.00
COPD 15.98 7.39* 0.4 to 14.9 2.07
Fort McPherson 13.04 1.13 –3.7 to 6.2 0.45
MI 12.68 –5.35 –11.7 to 1.5 –1.55
COPD 13.78 7.10 0.05 to 14.7 1.97
Yorkville 8.35 2.71 –1.3 to 6.9 1.31
MI 7.99 –3.63 –9.0 to 2.0 –1.27
COPD 8.52 8.23* 2.2 to 14.6 2.72
NO2
Mean of SAM sites 10.66 –0.49 –5.4 to 4.7 –0.19
MI 9.25 –13.88* –22.1 to –4.7 –2.88
COPD 11.97 6.89* 0.1 to 14.2 1.97
Tucker 13.75 –1.61 –5.9 to 2.9 –0.71
MI 12.88 –10.36* –17.7 to –2.4 –2.53
COPD 13.75 3.75 –2.1 to 10.0 1.24
South Dekalb 12.06 0.57 –4.7 to 6.1 0.21
MI 11.06 –6.50 –14.6 to 2.4 –1.45
COPD 12.19 4.99 –1.7 to 12.2 1.44
Data are percent change in overall SDNN expressed per IQR change in ambient PM2.5. Model does not include heart rate.
*Statistically signiﬁcant estimate.individuals (Creason et al. 2001; Gold et al.
2000), elderly individuals with preexisting
cardiovascular-related conditions (Liao et al.
1999), and occupationally exposed, middle-
aged boilermakers (Magari et al. 2002).
In contrast, our ﬁnding of positive associa-
tions between PM2.5 and HRV for individuals
with COPD is in direct contrast to findings
from the only other published study of pollu-
tion effects on HRV in individuals with COPD
(Brauer et al. 2001), in which HRV was meas-
ured repeatedly for 16 individuals with mild-
to-moderate COPD (FEV1 ≥ 0.75 L) living in
Vancouver, British Columbia, Canada. For
these individuals, nonsignificant ambient
PM2.5-associated decrements in SDNN and
RMSSD were found, with the lack of statisti-
cal signiﬁcance attributed to low ambient pol-
lution levels and the small sample size. The
negative direction of the PM2.5–HRV associa-
tion in Vancouver was comparable in magni-
tude to that observed in elderly individuals
living in Boston (Gold et al. 2000). The con-
trasting PM2.5 and HRV associations for the
Vancouver (Brauer et al. 2001) and our
COPD cohorts may result from the fact that
the Vancouver cohort had less severe pul-
monary disease compared with our cohort (as
defined by the self-reported physician diag-
noses). Positive associations between HRV
and PM2.5 have been demonstrated previously
in a study of a young, healthy cohort of high-
way patrolmen (Riedeker et al. 2004). For
these healthy patrolmen, SDNN increased sig-
nificantly by 11.7% per 10 μg/m3 in PM2.5
exposures. This increase is comparable to our
7.5% increase for a similar change in ambient
PM2.5 (10.64 μg/m3). Positive associations for
the patrolmen were attributed to increased
vagal activity in the young and healthy cohort.
Cardiovascular autonomic neuropathy is
common, although not universal, in patients
with COPD (Chhabra 2005). Although many
patients with COPD have marked baseline
sympathetic activation (Heindl 2001), indi-
viduals with COPD have been demonstrated
to respond to stimuli such as exercise with
increased vagal tone as measured by increases
in HF (Bartels et al. 2003). It is possible that
ambient pollution has similar effects on
increases in vagal tone among at least some
subsets of patients with COPD.
Because our COPD participants were gen-
erally older and less active than our MI partici-
pants, it is difﬁcult to determine whether the
observed effect modiﬁcation by disease group
reﬂect differences in the participant characteris-
tics or in the diseases themselves. Of the
patient characteristics, medication use was an
important modiﬁer of the HRV–PM2.5 associ-
ations. Individuals with COPD and MI were
generally prescribed different medications, with
beta-blocker and bronchodilator use limited
largely to individuals with a recent MI and
COPD, respectively. Correspondingly, effect
estimates for subjects taking beta-blockers
exhibited similar trends as those for subjects
with an MI, whereas effect estimates for sub-
jects taking bronchodilators were consistent
with those for individuals with COPD. As a
result of this strong overlap between medica-
tion use and disease group, it is not possible to
separate the effects of medication use from dis-
ease in this study.
Baseline pulmonary function, as measured
using baseline FEV1, was also found to modify
the association between ambient PM2.5 and
SDNN. From our linear model estimating the
modiﬁcation of PM2.5 effects by level of FEV1,
we estimate that the PM2.5–HRV association
decreased significantly with increasing pul-
monary function, comparable to a 10.2%
increase in SDNN for an IQR change in ambi-
ent PM2.5 for individuals with poor pulmonary
function (baseline FEV1 35% of predicted)
and a 2.5% decrease in SDNN for individuals
with normal lung function (baseline FEV1
105% of predicted). Because the baseline pul-
monary function was normal and narrowly
distributed for individuals with recent MI, the
observed impact of baseline pulmonary func-
tion on the PM2.5–SDNN response largely
reﬂects variation in baseline pulmonary func-
tion among individuals with COPD. Because
the inﬂuence of baseline pulmonary function
on HRV was not examined in previous stud-
ies, it is unknown whether baseline pul-
monary function had similar impacts on the
PM-associated HRV response in the previ-
ously reported studies. Evidence from cardio-
vascular health studies, however, suggests that
respiratory health status may be an important
modifier of the pollution-mediated auto-
nomic response, because HRV in individuals
with COPD has also been shown to decrease
with FEV1 (Stein et al. 1998). Negative asso-
ciations between average HRV and baseline
FEV1, however, were not observed in our
COPD cohort.
Results for PM2.5 were robust with respect
to location of the SAM site because results
were comparable when PM2.5 concentrations
at individual SAM sites were used as the expo-
sure measure, suggesting that spatial variation
in PM2.5 was not a signiﬁcant source of expo-
sure error for our study participants. For NO2,
similar sensitivity results show consistent
trends in the NO2–HRV associations by dis-
ease group. Larger differences in the effect esti-
mates, however, were found with different
methods to estimate ambient NO2 exposures,
suggesting that exposure error due to spatial
variability was greater for NO2 compared with
PM2.5. This greater exposure error is consis-
tent with the fact that trafﬁc, which varies spa-
tially over short distances, is a significant
source of outdoor NO2. Although comparable
sensitivity analyses could not be conducted for
BC, significant correlations between 24-hr
concentrations measured at the Jefferson St.
and Yorkville sites suggest that BC concentra-
tions measured at the Jefferson St. SAM site
were able to reﬂect BC concentrations across
Atlanta. Because these correlations were more
moderate compared with those for PM2.5 and
were similar in magnitude to those for NO2, it
is likely that spatial variation in outdoor BC
levels contributed to error in our exposure esti-
mates and thus may have affected our
observed effect estimates. For both NO2 and
BC, this greater exposure error may explain
the lower and insignificant effect estimates
found for these pollutants.
One important limitation of this investi-
gation is the small number of individuals
studied, with only 18 and 12 individuals with
COPD and a recent MI, respectively. Our
ﬁndings of effect modiﬁcation by medication
use and baseline pulmonary function, COPD,
and a recent MI, however, were consistent
with our ﬁndings of differential susceptibility
for individuals with COPD and a recent MI.
Further study is needed to identify factors
responsible for this differential susceptibility
and to identify whether the autonomic
response of individuals with other health con-
ditions also differ after ambient pollution
exposures.
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